精品丝袜无码一区二区三区,av无码国产在线看免费app

NEWS

2022/12/30 Correctseq

transformer Base Editor of Correctseq Wins the 19th People's Ingenuity Award

The 2022 People's Financial Summit Forum, hosted by www.people.cn online, was held in Beijing on Dec 29. The winners of the 19th People's Ingenuity Award were officially released at the forum. transformer Base Editor (tBE), which is developed by the scientific co-founders of CorrectSequence Therapeutics (Correctseq), won the Ingenuity Award for its higher editing efficiency and better safety in the whole genome and whole transcriptome, and promising to completely cure single base genetic diseases. Correctseq also became the only biotech pharmaceutical company to receive this award.

Details
2022/12/17 Correctseq

Oriental Financial Pudong Channel Dialogue 22 Interview with Dr. Xiaodun Mou, CEO of Correctseq

Recently, Dr. Xiaodun Mou, CEO of CorrectSequence Therapeutics, visited the "Dialogue 22" column of Oriental Financial Pudong Channel to share how to use creative gene editing technology to develop low-cost and high-quality therapy for people with severe diseases.

Details
2022/11/18 Correctseq

Mr. Edwin Lan, Head of CMC-MFG, Ex vivo Platform of Correctseq, Participates in the 4th Bio-ONE Forum and Makes a Speech

Nov 17-18, 2022, the 4th Bio-ONE Forum was hold in Shanghai. Mr. Edwin Lan, head of CMC-MFG, Ex vivo Platform of CorrectSequence Therapeutics (Correctseq), participated in the forum and made a speech titled CMC on ex vivo Platform.

Details
2022/11/15 Correctseq

Dr. Mou, CEO of Correctseq, Wins Prize of Annual Influential Enterprise Leaders of Chinese CGT Field in 2022

Nov 10, 2022, Dr. Mou, CEO of Correctseq, won the Pharma Big Star prize of Annual Influential Enterprise Leaders of Chinese CGT Field in 2022 in Shanghai (Minhang) Biomedical Industry Innovation Summit Award Ceremony of 2022. The prize list was selected by MedClub of emedclub.com together with industry experts.

Details
2022/10/15 e-Safe

Dr. Mou, CEO of Correctseq, Participates in Cell and Gene Therapy Non-Clinical Evaluation Salon and Makes a Speech

Oct 15, 2022, the Fourth Cell and Gene Therapy Non-Clinical Evaluation Salon organized by Drug Toxicology Committee of Chinese Pharmacological Society, Drug Toxicology and Safety Evaluation Committee of Chinese Society of Toxicology, and Tsinghua University, was successfully held online. The salon’s theme was Oncolytic Viruses, Gene Editing and R&D Cases. Dr. Mou, CEO of Correctseq, participated in the salon and made a speech titled How to Create Innovative Gene Editing System and Make Its Clinical Application Safety. The Chairman of Drug Toxicology and Safety Evaluation Committee of Chinese Society of Toxicology, Dr. Mingyang Liao participated in the salon and make an opening speech. The Chairman of the salon, Deputy Editor-in-Chief of Tsinghua University Press, Yu Sun, and the Chairman of the salon, Deputy Chairman and Secretary-General of Drug Toxicology and Safety Evaluation Committee of Chinese Society of Toxicology, Vice President of Suzhou Pharmaceutical Research Institute, Quanjun Wang hosted the salon.

Details
2022/10/12 Sequoiacap

[Sequoia Talk] Jiang Han x Xiaodun Mou: Turning Scissor into Pen, Base Editing Technology Leads Cell and Gene Therapy into Minimally Invasive Era

Following the successful holding of the first science and technology event, Sequoia Talk series Forum medical event recently came to a successful conclusion. In the gene editing session, Mr. Jiang Han, Director & General Manager of Sequoia China, and Dr. Xiaodun Mou, CEO of CorrectSequence Therapeutics (Correctseq), presented a wonderful sharing of cutting-edge gene editing technologies and innovative treatment solutions with the theme of "Turning Knife into Pen, Base Editing Leads Cell and Gene Therapy into Minimally Invasive Era".

Details
2022/08/05 Correctseq

Dr. Lijie Wang of Correctseq Participates in the NMPAIOED Drug Researcher Online Conference and Makes a Speech

On Aug 2-4, 2022, National Medical Products Administration Institute of Executive Development hold Drug Researcher Conference online. Dr Lijie Wang, head of CorrectSequence Therapeutics (Correctseq) Gene Editing Platform, was invited to attend the conference and made a speech on the topic of “the Latest Advances and Clinical Applications of Gene Editing”. (Online Live| Drug Researcher Conference( Topic: Biologics Registration Regulations and Applications)

Details
2022/08/01 SciPhi

Develop Innovative Base Editing System and Nearly 10 Pipelines, 1st Pipeline be IND Ready By 2023

Recently, CorrectSequence Therapeutics (Correctseq), a biotechnology company aims to use their own innovative gene editing system to help people living with serious diseases, announced that transformer Base Editor (tBE) developed independently is authorized by USPTO (United States Patent and Trademark Office) formally and became the Chinese first base editing tool authorized by overseas patents.

Details